Laura Agensky
Plus aucun poste en cours
Profil
Laura Agensky worked as Vice President-Clinical Operations at Transition Therapeutics, Inc. She obtained an undergraduate degree and an MBA from McGill University.
Anciens postes connus de Laura Agensky
| Sociétés | Poste | Fin |
|---|---|---|
| TRANSITION THERAPEUTICS INC | Directeur des opérations | 21/06/2009 |
Formation de Laura Agensky
| McGill University | Masters Business Admin |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Transition Therapeutics, Inc.
 Transition Therapeutics, Inc. Medical SpecialtiesHealth Technology Transition Therapeutics, Inc. develops novel therapeutics for disease indications. It operates through research and development of therapeutic agents segment. The firm's products include ELND005 for the treatment of alzheimer's disease, bipolar disorder and down syndrome. Its metabolic drug candidate is TT401 for treatment of type 2 diabetes and accompanying obesity. Transition Therapeutics was founded by Tony F. Cruz on July 6, 1998 and is headquartered in Toronto, Canada. | Health Technology |